Last updated: December 13, 2023
Sponsor: University of British Columbia
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Coronary Angiography
Clinical Study ID
NCT05075590
H21-01704
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients undergoing elective transfemoral TAVR with the Evolut THV (Medtronic,Minneapolis, MN, USA).
- Written informed consent to participate in the study.
Exclusion
Exclusion Criteria:
- Hemodynamic or respiratory instability immediately prior to TAVR or during TAVR.
- Advanced chronic kidney disease, defined as a GFR <30 ml/min.
- Valve-in-valve TAVR
- Prior CABG
- Aorto-ostial coronary artery disease.
- Prior PCI of the left main or right coronary ostium
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Coronary Angiography
Phase:
Study Start date:
October 27, 2021
Estimated Completion Date:
July 31, 2024
Study Description
Connect with a study center
St. Paul's Hospital
Vancouver, British Columbia V6Z 1Y6
CanadaActive - Recruiting
Vancouver General Hospital
Vancouver, British Columbia V5Z 1M9
CanadaActive - Recruiting
Sunnybrook Health Sciences Centre
Toronto, Ontario M4N 3M5
CanadaSite Not Available
UPMC Harrisburg
Harrisburg, Pennsylvania 17101
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.